Growing Kansas City's Medical Research, From Discovery To Cure

Champion: Dr. Patrick James, Quest Diagnostics
 
The translational research initiative can take fundamental medical research beyond the lab into clinical trials to develop therapies and cures that lead to better outcomes for chronic diseases, child healthcare, cancer, and other health issues affecting Americans.

 
 

May, 2016 Update


Four years after designation as a National Cancer Institute (NCI) cancer center, the University of Kansas Cancer Center will soon submit its application for designation as an NCI Comprehensive Cancer Center.


 
 

March 25, 2014 update


KU Medical Center researchers receive more than $10 million to pursue new translational research projects.

 

October 8, 2013 update


This initiative has three components: (1) supporting the University of Kansas Cancer Center in its efforts to secure National Cancer Institute designation; (2) leveraging the $20 million NIH Clinical and Translational Science Award (CTSA) grant awarded to KU Medical Center and that includes a number of regional partners by raising additional research funds to expand the scope of the collaboration, and, (3) exploring the feasibility and funding options to establish an Institute for Translational Research.
 
Progress to date and next steps:
The University of Kansas Cancer Center successfully received initial designation as an NCI cancer center in July, 2012. NCI designation is the highest recognition for an academic cancer center, opening doors to expanded research funding and related economic benefits and jobs, and bringing the most advanced cancer care to patients including access to clinical trials only available at NCI-designated centers. NCI grant funding grew 34% in 2012 to $13.9M with total extramural funding of over $56M. From 2007-2012 investments in NCI pursuit have had a regional economic impact of $931M with 1,830 new jobs created.  Read More >>
 
 

March 29, 2013 update


Progress to date and next steps:
Additional research funds are being raised for expansion of the CTSA grant.

Frontiers awarded pilot grants of up to $30,000 to 21 area researchers, including scientists at University of Kansas Medical Center, University of Missouri-Kansas City, the University of Kansas, and Children’s Mercy Hospitals and Clinics.
 
Business and civic leaders continue to develop funding options for the creation of an Institute for Translational Research.

The science advisors continue to be positive and supportive of the concept, commenting, “You’ve got something very special in KC.”

“Next Generation Medicine” will be used to communicate the concept because translational research is often difficult to understand.

Kansas City Area Life Sciences Institute reported a 17 percent growth in number of regional life sciences companies over the past three years. The report showed 240 life sciences companies in the 24-county Kansas City region last year, up from 206 companies in 2009.

 

February 5, 2013 update


 
 

September 12, 2012 update

 
This initiative has two components: (1) leveraging the $20 million NIH Clinical and Translational Science Award (CTSA) grant recently awarded to KU Medical Center and a number of regional partners by raising additional research funds to expand the scope of the collaboration, and (2) exploring the feasibility and funding options to establish an Institute for Translational Research. For additional information on the CTSA collaboration, see: www.kumc.edu/frontiers.html.
 
Progress to date:
“Big KC’s” life sciences research and patient care capabilities took a significant leap forward with the announcement in July that the University of Kansas Cancer Center received designation as a National Cancer Institute (NCI).
Additional research funds are being raised for expansion of the CTSA grant.
 
Business and civic leaders met with members of the Science Advisory Board to continue discussions on creation of an Institute for Translational Research.
The science advisors continue to be positive and supportive of the concept, commenting, “You’ve got something very special here.”
 
Next steps:
Clarify message and increase visibility of the regional translational research initiative.
Secure funding.

 

June, 2012 Update


University of Kansas Cancer Center earns prestigious designation as a National Cancer Institute (NCI) cancer center.